Probing plasma clearance of the thrombin-antithrombin complex with a monoclonal antibody against the putative serpin-enzyme complex receptor-binding site

European Journal of Biochemistry

Volumn 270, Issue 20, 2003, Pages 4059-4069

  Long, George L ^a   Kjellberg, Margareta ^b   Villoutreix, Bruno O ^c   Stenflo, Johan ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b LUND UNIVERSITY   (Sweden)

^c INSERM   (France)

Author keywords

Antithrombin; Monoclonal antibody; Serpin enzyme complex receptor; Thrombin; Thrombin antithrombin complex

Indexed keywords

ANTITHROMBIN; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY M27; SERINE PROTEINASE INHIBITOR; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING SITE; DRUG CLEARANCE; DRUG EFFECT; DRUG INHIBITION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MOLECULAR MODEL; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTITHROMBIN III; BLOTTING, WESTERN; CATTLE; EPITOPES; HUMANS; PEPTIDE HYDROLASES; RABBITS; SERPINS; THROMBIN; TIME FACTORS;

ANIMALIA;

EID: 0142120491     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2003.03793.x     Document Type: Article

References (50)

1. Carrell, R.W. & Stein, P.E. (1996) The biostructural pathology of the serpins: critical function of sheet opening mechanism. Biol. Chem. Hoppe-Seyler. 377, 1-17.
2. Gettins, P.G.W., Patston, P.A. & Olsen, S.T. (1996) Serpins: Structure, Function and Biology. R. G. Landes, Austin, TX.
3. Gils, A. & Declerck, P.J. (1998) Structure-function relationships in serpins: current concepts and controversies. Thromb. Haemost. 80, 531-541.
4. Schulze, A.J., Huber, R., Bode, W. & Engh, R.A. (1994) Structural aspects of serpin inhibition. FEBS Lett. 334, 117-124.
5. Gettins, P.G.W. (2002) Serpin structure, mechanism, and function. Chem. Rev. 102, 4751-4803.
6. Miletich, J.P., Prescott, S.M., White, R., Majerus, P.W. & Bovill, E.G. (1993) Inherited predisposition to thrombosis. Cell 72, 477-480.
7. Florell, S.R. & Rodgers, G.M. (1997) Inherited thrombotic disorders: an update. Am. J. Hematol. 54, 53-60.
8. Fish, W.W., Orre, K. & Björk, I. (1979) The production of an inactive form of antithrombin through limited proteolysis by thrombin. FEBS Lett. 98, 103-106.
9. Carrell, R.W., Stein, P.E., Fermi, G. & Wardell, M.R. (1994) Biological implications of a 3Å structure for dimeric antithrombin. Structure 2, 257-270.
10. Huntington, J.A., Read, R.J. & Carrell, R.W. (2000) Structure of a serpin-protease complex shows inhibition by deformation. Nature 407, 923-926.
11. Wells, M.J., Sheffield, W.P. & Blajckman, M.A. (1999) The clearance of thrombin-antithrombin and related serpin-enzyme complexes from the circulation: role of various hepatocyte receptors. Thromb. Haemost. 81, 325-337.
12. Chang, W.-S.W., Wardell, M.R., Lomas, D.A. & Carrell, R.W. (1996) Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem. J. 314, 647-653.
13. Wardell, M.R., Chang, M.-S.W., Bruce, D., Skinner, R., Lesk, A.M. & Carrell, R.W. (1997) Preparative induction and chracterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1. Biochemistry 36, 13133-13142.
14. Carrell, R.W., Huntington, J.A., Mushunje, A. & Zhou, A. (2001) The conformational basis of thrombosis. Thromb. Haemost. 86, 14-22.
15. Zhou, A., Huntington, J.A. & Carrell, R.W. (1999) Formation of antithrombin heterodimer in vivo and the onset of thrombosis. Blood 94, 3388-3396.
16. Bruce, D., Perry, D.J., Borg, J.-Y., Carrell, R.W. & Wardell, M.R. (1994) Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn → Asp). J. Clin. Invest. 94, 2265-2274.
17. Chang, W.-S.W. & Harper, P.L. (1997) Commercial antithrombin concentrate contains inactive L-forms of antithrombin. Thromb. Haemost. 77, 323-328.
18. O'Reilly, M.S., Pirie-Shepherd, S., Lane, W.S. & Folkman, J. (1999) Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 285, 1926-1928.
19. Larsson, H., Sjöblom, T., Dixelius, J., Östman, A., Ylinenjärvi, K., Björk, I. & Claesson-Welsh, L. (2000) Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells. Cancer Res. 60, 6723-6729.
20. Perlmutter, D.H., Glover, G.I., Rivetna, M., Schasteen, C.S. & Fallon, R.J. (1990) Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes. Proc. Natl Acad. Sci. USA 87, 3753-3757.
21. Wells, M., Hatton, M.W.C., Hewlett, B., Podar, T.J., Scheffield, W.P. & Blajchman, M.A. (1997) Cytokeratin 18 is expressed on the hepatocyte plasma membrane surface and interacts with thrombin-antithrombin complexes. J. Biol. Chem. 272, 28574-28581.
22. Maekawa, H. & Tollefsen, D.M. (1996) Role of the proposed serpin-enzyme complex receptor recognition site in binding and internalization of thrombin-heparin cofactor II complexes by hepatocytes. J. Biol. Chem. 271, 18604-18609.
23. McKay, E.J. (1981) A simple two-step procedure for the isolation of antithrombin III from biological fluids. Thromb. Res. 21, 375-382.
24. Picard, V., Marque, P.-E., Paolucci, F., Aiach, M. & Le Bonniec, B.F. (1999) Topology of the stable serpin-protease complexes revealed by an autoantibody that fails to react with the monomeric conformers of antithrombin. J. Biol. Chem. 274, 4586-4593.
25. Bajaj, S.P. & Mann, K.G. (1973) Simultaneous purification of bovine prothrombin and factor X. Activation of prothrombin by trypsin-activated factor X. J. Biol. Chem. 248, 7729-7741.
26. Speijer, H., Govers-Reimslag, J.W.P., Zwall, R.F.A. & Rosing, J. (1986) Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan Snake). J. Biol. Chem. 261, 13258-13267.
27. Strandberg, K., Kjellberg, M., Erb, E.-M., Persson, U., Mosher, D.F., Villoutreix, B.O. & Stenflo, J. (2000) Activated protein C-protein C inhibitor complex formation: characterization of a neoepitope provides evidence for extensive insertion of the reactive center loop. Biochemistry 39, 15713-15720.
28. Harlow, E. & Lane, D. (1988) Antibodies - A Laboratory Manual. CSH Laboratory, Cold Spring Harbor, NY.
29. Parham, P. (1986) Preparation and purification of active fragments from mouse monoclonal antibodies. In: Cellular Immunology, (Weir, D.M., ed), 4th edn, Vol. 1, pp. 14.1-14.23. Blackwell Scientific Publications, Maiden, MA.
30. Brown, M.A., Stenberg, L.M., Perrson, U. & Stenflo, J. (2000) Identification and purification of vitamin K-dependent proteins and peptides with monoclonal antibodies specific for γ-carboxyglutamyl (Gla) residues. J. Biol. Chem. 275, 19795-19802.
31. Cowan, N.J., Secher, D.S. & Milstein, C.J. (1974) Intracellular immunoglobulin chain synthesis in non-secreting variants of a mouse myeloma: detection of inactive light chain messenger RNA. J. Mol. Biol. 90, 691-701.
32. Schreuder, H.A., De Boer, B., Dijkema, R., Mulders, J., Theunisson, H.J.M., Grootenhuis, P.D.J. & Hol, W.G.J. (1994) The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nat. Struct. Biol. 1, 48-54.
33. Skinner, R., Abrahams, J.P., Whisslock, J.C., Lesk, A.M., Carrell, R.W. & Wardell, M.R. (1997) The 2.6 Å structure of antithrombin indicates a conformational change at the heparin binding site. J. Mol. Biol. 266, 601-609.
34. Mourny, L., Samama, J.P., Delarue, M., Petitou, M., Choay, J. & Moras, D. (1993) Crystal structure of cleaved bovine antithrombin III at 3.2 Å resolution. J. Mol. Biol. 232, 223-241.
35. Lee, B. & Richards, F.M. (1971) The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55, 379-400.
36. Kurochking, N. & Privalov, G. (1998) Heterogeneity of packing: Structural approach. Protein Sci. 7, 897-905.
37. Wu, J.K., Sheffield, W.P. & Blajchman, M.A. (1992) Molecular cloning and cell-free expression of mouse antithrombin III. Thromb. Haemost. 68, 291-296.
38. 1-antitrypsin-proteinase complex. J. Biol. Chem. 266, 11282-11288.
39. 1-antitrypsin-trypsin complexes is mediated by the low density lipoprotein receptor-related protein. J. Biol. Chem. 271, 6523-6529.
40. Asakura, S., Matsuda, M., Yoshida, N., Terukina, S. & Kihara, H. (1989) A monoclonal antibody that triggers deacylation of an intermediate thrombin-antithrombin III complex. J. Biol. Chem. 264, 13736-13739.
41. Asakura, S., Hirata, H., Okazaki, H., Hashimoto-Gotoh, T. & Matsuda, M. (1990) Hydrophobic residues 382-386 of antithrombin III, Ala-Ala-Ala-Ser-Thr, serve as the epitope for an antibody which facilitates hydrolysis of the inhibitor by thrombin. J. Biol. Chem. 265, 5135-5138.
42. Dawes, J., James, K. & Lane, D.A. (1994) Conformational change in antithrombin induced by heparin, probed with a monoclonal antibody against the 1C/4B region. Biochemistry 33, 4375-4383.
43. Olson, S.T. & Björk, I. (1991) Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects. J. Biol. Chem. 266, 6353-6364.
44. Lollar, P. & Owen, W.G. (1980) Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible roles in the inactivation of thrombin by antithrombin III. J. Clin. Invest. 66, 1222-1230.
45. 2-macroglobulin-methylamine. Biochim. Biophys. Acta 716, 151-157.
46. Pratt, C.W., Church, F.C. & Pizzo, S.V. (1988) In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors. Arch. Biochem. Biophys. 262, 111-117.
47. 2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry 30, 1723-1730.
48. Ziady, A.G., Perales. J.C., Ferkol, T., Gerken, T., Beegen, H., Perlmutter, D.H. & Davis, P.B. (1997) Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor. Am. J. Physiol. 273, G545-G552.
49. Patel, S., Zhang, X., Collins, L. & Fabre, J.W. (2001) A small synthetic peptide for gene delivery via the serpin-enzyme complex receptor. J. Gene Med. 3, 271-279.
50. Zaidy, A.G., Ferkol, T., Dawson, D.V., Perlmutter, D.H. & Davis, P.B. (1999) Chain length of the polylysine in receptor-targeted transfer complexes affects duration of reporter gene expression both in vitro and in vivo. J. Biol. Chem. 274, 4908-4916.